XTalks

NOVEMBER 30, 2023

This candidate, derived from a person’s own genetically modified cells, aims to restore the Gag-specific CD4+ T cell response in those receiving antiretroviral therapy. In addition, Vir Biotechnology, Inc. announced the initiation of a Phase I trial for its innovative HIV vaccine candidate, VIR-1388.

FDA Approval 111

FDA Approval Gene Therapy Clinical Trials Clinical Trials 111

The Pharma Data

JUNE 25, 2021

“These data show consistent, high levels of efficacy and reaffirm the ability of the vaccine to prevent COVID-19 amid ongoing genetic evolution of the virus. Department of Health and Human Services (HHS), and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) at HHS.

Vaccination 40

Vaccination Vaccine Trials Immune Response 40

The Pharma Data

FEBRUARY 22, 2021

Meiogenix’s proprietary technologies are used to induce the exchange of genomic regions between chromosomes of plant cells during meiosis, the natural process that generates genetic diversity during plant breeding. Improving diets through increased quality and access.

Gene Editing 40

Gene Editing Genomics Genome Protein 40

Trialfacts

NOVEMBER 26, 2023

It offers undergraduate and graduate degree programs in the sciences, humanities, social sciences, business, engineering, and other fields. Must not currently be taking any protein or weight loss supplements or medications known to affect protein metabolism (i.e., It was founded in 1887 through a gift from Sen. William McMaster.

Research 52

Research Protein Insulin Allergies 52

Scienmag

FEBRUARY 23, 2021

Viruses make copies of themselves during an infection, and new research sheds light on one of the coronavirus molecules that is important for this process, providing a potential drug target that could work for Covid-19 and other coronavirus outbreaks too. Credit: Image courtesy of Keith Mickolajczyk.

Drugs 61

Drugs Research Allergies Genetics 61

Scienmag

MARCH 1, 2021

Credit: Earlham Institute Respiratory viruses such as SARS-CoV-2 (causing COVID-19) can often catalyse an overactive immune response that leads to a life-threatening cycle, known as a cytokine storm.

Immune Response 59

Immune Response Bioinformatics Allergies Genetics 59

Scienmag

OCTOBER 19, 2020

Garrido, CNIO The sophisticated human immune system has evolved to become an effective protection system against a great number of diseases, cancer being one of them. The immune system recognises and destroys cancer cells using a monitoring process called immunological surveillance.

Dermatology 52

Dermatology Allergies Gene Genetics 52

Scienmag

JUNE 8, 2021

Katalin Karikó receives the 2022 Vilcek Prize for Excellence in Biotechnology for her scientific contributions that led to the development of mRNA vaccines for COVID-19 NEW YORK, June 8, 2021–Dr.

Vaccination 50

Vaccination Vaccine Development Research 50

Scienmag

SEPTEMBER 15, 2020

Molecular clock analysis showed no widespread ‘community’ distribution of the highly contagious coronavirus disease in Arizona until mid-February FLAGSTAFF, Ariz. — Sept.

Genomics 40

Genomics Genome Allergies Genetics 40

Scienmag

DECEMBER 22, 2020

Around a third of the world’s population carries Toxoplasma gondii, a parasite that puts people with a weakened immune system at risk and can trigger malformations in the womb. The single-celled pathogen also leads to economic losses in agriculture, with toxoplasmosis increasing the risk of abortion among sheep, for example.

Genetic Engineering 40

Genetic Engineering Engineer Genetics Allergies 40

XTalks

DECEMBER 24, 2020

However, for virologists like Lori Frappier, PhD, professor in the department of molecular genetics at the University of Toronto, the outbreak of SARS-CoV-2 was less of a surprise and more of an inevitability. She told Xtalks that, “Experts have always known that this kind of pandemic was a possibility, especially with coronaviruses.

Life Science 111

Life Science Vaccination Vaccine Gene 111

XTalks

SEPTEMBER 14, 2020

These companies include Moderna, a US biotech company which has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID), Oxford University who has partnered with AstraZeneca, and Johnson & Johnson, Merck and Pfizer.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92